Tempus AI's TIME Honor And USC Deal Test Its Long Term Thesis [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Tempus AI (NasdaqGS:TEM) was named to TIME's 10 Most Influential Health and Life Science Companies of 2026. The company expanded its clinical and research reach through a multi year collaboration with the Keck School of Medicine of USC and Keck Medicine of USC. The partnership is aimed at advancing AI driven precision medicine and applying Tempus tools across patient care and research programs. Tempus AI focuses on applying artificial intelligence to precision medicine, with products that include the FDA approved xT CDx test and a growing suite of data and diagnostic tools. The TIME recognition and new USC collaboration sit alongside recent acquisitions and product approvals that have shaped how Tempus positions itself within health care and life sciences. For investors, these updates relate to real world adoption and external validation rather than short term trading catalysts. Looking ahead, readers may want to watch how this USC relationship is integrated into Tempus AI's
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health to Participate in Upcoming Investor ConferencesBusiness Wire
- Roche builds MRD testing arsenal in $595m Saga Diagnostics buyout [Yahoo! Finance]Yahoo! Finance
- Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026Business Wire
- Guardant Health (GH) had its "overweight" rating reaffirmed by Barclays PLC.MarketBeat
- Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know [Yahoo! Finance]Yahoo! Finance
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 4/28/26 - Form ARS
- 4/28/26 - Form DEFA14A
- 4/28/26 - Form DEF
- GH's page on the SEC website